🕵️ Alamar Biosciences, Inc. ($ALMR)

SEC insider & ownership activity, last 12 months · CIK 2104204 · every row links its SEC filing

Over the last 12 months insiders bought $8.0M with no open-market selling against it. Illumina Innovation Fund II GP, L.L.C. bought $4.0M in discretionary trades (Apr). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net +$0 Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$8.0M May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

2 buyers, $8.0M (2 lots) · 0 sellers, $0 (0 lots)

InsiderBuysBoughtSellsSoldLast
Illumina Innovation Fund II GP, L.L.C.1$4.0M 0–Apr 20, 2026
Naclerio Nicholas1$4.0M 0–Apr 20, 2026

5%+ holders

HolderStakeClassScheduleEvent
Nicholas Naclerio 9.6% 13DApr 20, 2026 filing ↗
Illumina Innovation Fund II GP, L.L.C. 8.8% 13DApr 20, 2026 filing ↗
Illumina Innovation Fund II, L.P. 8.8% 13DApr 20, 2026 filing ↗
Daqing Cai 7.2% 13GJul 2, 2026 filing ↗
Sands Capital Life Sciences Pulse Fund II, L.P. 6.1% 13DJul 5, 2026 filing ↗
Sands Capital Alternatives, LLC 6.1% 13DJul 5, 2026 filing ↗
Frank M. Sands 6.1% 13DJul 5, 2026 filing ↗
Sherpa Healthcare Fund II, L.P. 5.7% 13GJul 2, 2026 filing ↗
Sherpa Healthcare Fund II GP, Ltd. 5.7% 13GJul 2, 2026 filing ↗
Sherpa Healthcare Co-Investment Fund, L.P. exited 13GJul 2, 2026 filing ↗
Sherpa Healthcare Co-Investment GP Ltd. exited 13GJul 2, 2026 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Other events (8.01)Jul 15, 2026 filing ↗
Earnings (2.02)May 8, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 8, 2026 filing ↗
Charter/bylaw changes (5.03)Apr 20, 2026 filing ↗
Other events (8.01)Apr 20, 2026 filing ↗
Financial Statements and Exhibits (9.01)Apr 20, 2026 filing ↗